Lung toxicity following fludarabine, cytosine arabinoside and mitoxantrone (flan) treatment for acute leukemia

Haematologica. 2000 Jul;85(7):769-70.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Antineoplastic Combined Chemotherapy Protocols / toxicity*
  • Cytarabine / administration & dosage
  • Cytarabine / toxicity
  • Hemorrhage / etiology
  • Humans
  • Infant, Newborn
  • Leukemia / complications
  • Leukemia / drug therapy*
  • Leukemia, Myeloid, Acute / complications
  • Leukemia, Myeloid, Acute / drug therapy
  • Lung Diseases / chemically induced*
  • Lung Diseases / complications
  • Male
  • Mitoxantrone / administration & dosage
  • Mitoxantrone / toxicity
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / complications
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / drug therapy
  • Respiratory Distress Syndrome, Newborn / chemically induced
  • Staphylococcal Infections / chemically induced
  • Vidarabine / administration & dosage
  • Vidarabine / analogs & derivatives
  • Vidarabine / toxicity

Substances

  • Cytarabine
  • Mitoxantrone
  • Vidarabine
  • fludarabine

Supplementary concepts

  • FLAM regimen